Real-time enrollment status for this hypoparathyroidism clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:41 PM UTC
| NCT Number | NCT07805356 |
| Recruiting Status | Recruiting |
| Condition | Hypoparathyroidism |
| Phase | PHASE3 |
| Target Enrollment | 160 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Calcilytix Therapeutics, Inc., a BridgeBio company |
| Last Updated on CT.gov | September 16, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT07805356 is currently recruiting participants. This phase3 study for hypoparathyroidism is actively seeking new participants at 4 locations across the United States. The study is sponsored by Calcilytix Therapeutics, Inc., a BridgeBio company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07805356 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07805356 was last updated 3 weeks ago (September 16, 2026). HelloStudys verifies this status automatically.